• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Life Sciences Investor Forum Agenda Announced for March 13th

    3/12/25 1:12:37 PM ET
    $CGTX
    $COCP
    $FBLG
    $PDSB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $CGTX alert in real time by email

    NEW YORK, March 12, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series announced the agenda for the Life Sciences Investor Forum March 13th. This event is co-hosted by Zacks Small Cap Research.

    Individual investors, institutional investors, advisors, and analysts are invited to attend.

    REGISTER NOW AT:   https://bit.ly/4hnure6

    It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There is no cost to log-in, attend live presentations, or schedule 1x1 meetings with management.

    "We look forward to bringing together innovators from the life sciences sector," said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group. "This Virtual Investor Conference co-hosted by Zack's Small Cap Research, will provide an efficient platform for these companies to seamlessly engage and broaden their investor base." 

    March 13th

    Eastern

    Time (ET)
    PresentationTicker(s)
    9:30 AM ETCognition Therapeutics, Inc.(NASDAQ:CGTX)
    10:00 AM ETBiophytis SA(OTC:BPTSY, FP: ALBPS))
    10:30 AM ETAvicanna Inc.(OTCQX:AVCNF, TSX:AVCN)
    11:00 AM ETPsy Therapeutics, Inc.Private
    11:30 AM ETCocrystal Pharma, Inc.(NASDAQ:COCP)
    12:00 PM ETNervGen Pharma Corp.(OTCQB:NGENF, TSXV:NGEN)
    12:30 PM ETFibroBiologics, Inc.(NASDAQ:FBLG)
    1:00 PM ETTelescope Innovations Corp.(OTCQB:TELIF, CSE:TELI)
    1:30 PM ETRafarma Pharmaceuticals, Inc.(OTC:RAFA)
    2:00 PM ETIzotropic Corporation(OTCQB:IZOZF, CSE:IZO)
    2:30 PM ETPDS Biotechnology Corporation(NASDAQ:PDSB)
    3:00 PM ETLadRX Corporation(OTCQB:LADX)
    3:30 PM ETTonix Pharmaceuticals Holding Corp.(NASDAQ:TNXP)
    4:00 PM ETHemostemix, Inc.(OTCQB:HMTXF, TSXV:HEM)



    To facilitate investor relations scheduling and to view a complete calendar of Virtual Investor Conferences, please visit www.virtualinvestorconferences.com.

    About Virtual Investor Conferences®

    Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.

    Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.

    Media Contact: 

    OTC Markets Group Inc. +1 (212) 896-4428, [email protected]

    Virtual Investor Conferences Contact:

    John M. Viglotti

    SVP Corporate Services, Investor Access

    OTC Markets Group

    (212) 220-2221

    [email protected]



    Primary Logo

    Get the next $CGTX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CGTX
    $COCP
    $FBLG
    $PDSB

    CompanyDatePrice TargetRatingAnalyst
    Cognition Therapeutics Inc.
    $CGTX
    12/19/2024$1.00 → $1.50Neutral → Buy
    B. Riley Securities
    FibroBiologics Inc.
    $FBLG
    12/12/2024$12.00Buy
    Rodman & Renshaw
    FibroBiologics Inc.
    $FBLG
    10/30/2024$12.00Buy
    H.C. Wainwright
    FibroBiologics Inc.
    $FBLG
    9/24/2024$12.00Buy
    Maxim Group
    Cognition Therapeutics Inc.
    $CGTX
    7/30/2024Overweight → Neutral
    Cantor Fitzgerald
    PDS Biotechnology Corporation
    $PDSB
    11/1/2022$10.00Buy
    B. Riley Securities
    Tonix Pharmaceuticals Holding Corp.
    $TNXP
    4/18/2022Outperform
    Noble Capital Markets
    Cognition Therapeutics Inc.
    $CGTX
    11/3/2021$27.00Buy
    B. Riley Securities
    More analyst ratings